Developer and Manufacturer of Implantable Neurostimulation and Brain-Computer Interface Products

Synthetic Biology Technology Developer
Contact Lens Provider

Developer of Robot-Assisted Minimally Invasive Surgical Systems
Click AboveBlue TextFollow Us

Recently, the first domestically-produced peripheral nerve stimulation system (PNS) in China, independently developed by SNEURO MEDICAL (Hangzhou Shenluo Medical Technology Co., Ltd.), has been approved for marketing. The system includes a peripheral nerve stimulation electrode (NMPA approval No. 20263120750), a peripheral nerve stimulator (Zhejiang NMPA approval No. 20262120207), and a peripheral nerve stimulator programmer (Zhejiang NMPA approval No. 20262120208). This marks a milestone breakthrough, filling the product gap in this field within China.

1. Redefining Neuromodulation: Technological Innovation in Treatment, Clinical Evidence in Efficacy
SNEURO MEDICAL has transformed neuro-modulation therapy from traditional "major surgery" to minimally invasive "outpatient procedures" through multiple proprietary patented designs, making treatment more accessible:
Puncture Implantation: Ultrasound-guided puncture implantation can be completed in an outpatient setting.
Ultra-Long Cycle Treatment: Up to 30 Days of Treatment.
Suture-Free Design: Unique suture-free design, no suturing required for the implant wound, avoiding secondary harm to the patient.
Anti-fall Design: Unique anti-displacement design prevents electrode displacement, ensuring continuous and effective treatment.
2. Excellent Efficacy: Based on High-Level Evidence
The prospective, multicenter, randomized controlled clinical trial of SNEURO MEDICAL's peripheral nerve stimulation system fully demonstrated its excellent safety and efficacy. The effective rate of pain relief ≥50% reached 96.00%, and indicators such as depression scores and quality of life impact showed significant improvement from baseline.


Boyu Partners News | Edge Medical's "Three-in-One" Surgical Robot Platform Receives NMPA Approval
